In:
The Journal of AMD, Societa Benefit AMD Srl SB, Vol. 25, No. 1 ( 2022-05), p. 31-
Abstract:
Good outcomes are obtained with early glycemic control, as shown by the UK Prospective Diabetes Study (UKPDS), but the legacy benefits continue ten years after the study ending, and are also present for lipid and blood pressure management. The ADA and EASD consensus report now has, for the first time, evidence-based recommendations: among them, on a blue circle on the top of the flowchart, it is recommended to “avoid clinical inertia”, and “to reassess and modify clinical treatment regularly, every 3-6 months”(1).
Type of Medium:
Online Resource
ISSN:
2532-4799
DOI:
10.36171/jamd22.25.1.5
Language:
Italian
Publisher:
Societa Benefit AMD Srl SB
Publication Date:
2022
Bookmarklink
